We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+6.6%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$3.3B
AUM Growth
+$481M
(+17%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
15.52%
Top 10 Holdings %
Top 10 Hldgs %
30.72%
Holding
1,380
New
403
Increased
148
Reduced
188
Closed
428
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$41.4M |
| 2 |
XLRN
Acceleron Pharma
XLRN
|
+$7.85M |
| 3 |
Bausch Health
BHC
|
+$7.4M |
| 4 |
Albemarle
ALB
|
+$6.62M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$6.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$24.4M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$10M |
| 3 |
Amgen
AMGN
|
+$7.37M |
| 4 |
Cracker Barrel
CBRL
|
+$5.6M |
| 5 |
Costco
COST
|
+$5.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.28% |
| 2 | Communication Services | 1.55% |
| 3 | Technology | 0.91% |
| 4 | Consumer Discretionary | 0.74% |
| 5 | Financials | 0.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
PUT
Aon
AON
$78.3B
| $2.86M | 0.09% |
+10,000
| New | +$2.69M |
|
227
PUT
Thermo Fisher Scientific
TMO
$214B
| $2.86M | 0.09% |
+5,000
| New | +$2.74M |
|
228
CALL
Zentalis Pharmaceuticals
ZNTL
$350M
| $2.84M | 0.09% |
+42,600
| New | +$2.46M |
|
|
CERN
229
CALL
DELISTED
Cerner Corp
CERN
| $2.82M | 0.09% |
40,000
-176,300
| -82% | -$13.6M |
|
230
CALL
Silicon Laboratories
SLAB
$7.15B
| $2.8M | 0.09% |
+20,000
| New | +$3M |
|
|
NBIS
231
CALL
Nebius Group N.V.
NBIS
$47.8B
| $2.79M | 0.08% |
35,000
| – | – |
|
|
TBCH
232
CALL
Turtle Beach Corp
TBCH
$243M
| $2.78M | 0.08% |
+100,000
| New | +$2.92M |
|
233
CALL
SoFi Technologies
SOFI
$21.1B
| $2.77M | 0.08% |
174,700
-106,400
| -38% | -$1.67M |
|
234
PUT
Royal Caribbean
RCL
$86.1B
| $2.76M | 0.08% |
31,000
| – | – |
|
235
CALL
General Motors
GM
$80B
| $2.74M | 0.08% |
52,000
-18,000
| -26% | -$957K |
|
|
SGI
236
Somnigroup International
SGI
$14.1B
| $2.71M | 0.08% |
58,500
-21,500
| -27% | -$939K |
|
237
PUT
AMN Healthcare
AMN
$1.35B
| $2.7M | 0.08% |
+23,500
| New | +$2.49M |
|
238
CALL
Generac Holdings
GNRC
$11.3B
| $2.7M | 0.08% |
+6,600
| New | +$2.83M |
|
239
CALL
Petrobras
PBR
$123B
| $2.69M | 0.08% |
+260,000
| New | +$2.77M |
|
240
PUT
United Natural Foods
UNFI
$3.01B
| $2.66M | 0.08% |
+55,000
| New | +$1.95M |
|
|
FLOW
241
PUT
DELISTED
SPX FLOW, Inc.
FLOW
| $2.65M | 0.08% |
+36,300
| New | +$2.76M |
|
242
PUT
Dell
DELL
$262B
| $2.63M | 0.08% |
98,650
+78,723
| +395% | +$3.92M |
|
243
CALL
CRISPR Therapeutics
CRSP
$4.77B
| $2.63M | 0.08% |
23,500
-26,400
| -53% | -$3.32M |
|
244
CALL
Gildan
GIL
$9.72B
| $2.63M | 0.08% |
72,000
| – | – |
|
|
CTLP
245
CALL
DELISTED
Cantaloupe
CTLP
| $2.61M | 0.08% |
242,500
-80,000
| -25% | -$828K |
|
246
PUT
Oracle
ORCL
$367B
| $2.61M | 0.08% |
+30,000
| New | +$2.65M |
|
247
CALL
FerroAtlántica
GSM
$600M
| $2.61M | 0.08% |
300,000
+133,400
| +80% | +$909K |
|
|
FISV
248
CALL
Fiserv Inc
FISV
$28.8B
| $2.6M | 0.08% |
24,000
| – | – |
|
|
MAG
249
CALL
DELISTED
MAG Silver
MAG
| $2.59M | 0.08% |
160,000
| – | – |
|
250
CALL
Cytokinetics
CYTK
$10.9B
| $2.59M | 0.08% |
+72,500
| New | +$2.13M |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q3 2021 Portfolio in Review
As of Q3 2021, SG3 Management held 1,380 positions worth $3.3B, up 17% from $2.82B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
SG3 Management deployed $512M of net new capital in Q3 2021, opening 403 new positions and adding to 148 existing holdings. Its largest new stake was Alphabet (Google) Class C: 300,000 shares worth $40M.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.3% a quarter earlier, followed by Communication Services and Technology.
On the sell side, the largest reduction was Bank of America, an estimated $4.85M trimmed.
- SG3 Management's largest Q3 2021 buy was Alphabet (Google) Class C: 300,000 shares worth $40M.
- SG3 Management added most to Bausch Health in Q3 2021, an estimated $7.4M increase.
- SG3 Management's biggest Q3 2021 reduction was Bank of America, cutting an estimated $4.85M.
- SG3 Management fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $24.4M.
- SG3 Management's ten largest holdings make up 31% of its $3.3B portfolio in Q3 2021.
- SG3 Management opened 403 new positions and closed 428 in Q3 2021.
- SG3 Management's portfolio value rose 17% quarter-over-quarter to $3.3B.
Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.